Faguang Jin Selected Research

tussilagone

5/2022

Tussilagone protects acute lung injury from PM2.5 via alleviating Hif-1α/NF-κB-mediated inflammatory response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Faguang Jin Research Topics

Disease

17	Acute Lung Injury 05/2022 - 12/2011
16	Lung Injury 05/2022 - 04/2011
14	Neoplasms (Cancer) 03/2022 - 09/2015
13	Inflammation (Inflammations) 06/2021 - 01/2013
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 10/2015
9	Lung Neoplasms (Lung Cancer) 03/2022 - 04/2008
6	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2021 - 12/2011
6	Pulmonary Edema 06/2017 - 01/2013
5	Hypertension (High Blood Pressure) 01/2021 - 01/2017
5	Edema (Dropsy) 01/2019 - 02/2013
5	Hypoxia (Hypoxemia) 06/2015 - 11/2012
4	Pneumonia (Pneumonitis) 09/2019 - 01/2014
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2018 - 12/2015
3	Drowning 06/2021 - 12/2011
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 10/2015
3	Diarrhea 01/2019 - 10/2016
3	Pathologic Constriction (Stenosis) 01/2018 - 01/2011
3	Dyspnea (Shortness of Breath) 01/2018 - 08/2010
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 04/2020 - 01/2019
2	Cough 02/2020 - 01/2015
2	Wounds and Injuries (Trauma) 01/2020 - 11/2013
2	Hand-Foot Syndrome 01/2019 - 11/2018
2	Hyperplasia 01/2018 - 01/2017
2	Necrosis 12/2016 - 03/2016
2	Carcinogenesis 12/2015 - 12/2010
2	Adenocarcinoma of Lung 09/2015 - 12/2010
2	Breast Neoplasms (Breast Cancer) 09/2015 - 11/2013
2	Tuberculosis (Tuberculoses) 06/2013 - 01/2011
1	Adenoid Cystic Carcinoma (Cylindroma) 03/2022
1	Atherosclerosis 01/2022
1	Fibrosis (Cirrhosis) 01/2019
1	Heart Diseases (Heart Disease) 01/2019
1	Hypothyroidism 01/2019

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 04/2018 - 12/2010
8	anlotinibIBA 05/2022 - 01/2018
6	CytokinesIBA 12/2016 - 02/2013
5	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 12/2015
5	ResveratrolIBA 11/2020 - 02/2013
5	Pharmaceutical PreparationsIBA 11/2018 - 08/2010
5	3,5,4'-tri-O-acetylresveratrolIBA 06/2018 - 01/2013
4	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 10/2015
3	Oxygen (Dioxygen)IBA 10/2021 - 01/2014
3	AntioxidantsIBA 10/2021 - 07/2015
3	LipopolysaccharidesIBA 07/2021 - 01/2015
3	Biological ProductsIBA 04/2018 - 11/2013
2	Particulate MatterIBA 05/2022 - 04/2020
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2022 - 01/2020
2	AcidsIBA 10/2021 - 05/2016
2	Interleukin-10 (Interleukin 10)IBA 03/2019 - 01/2014
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2018
2	Anaplastic Lymphoma KinaseIBA 01/2019 - 01/2018
2	Semaphorins (Semaphorin)IBA 10/2017 - 10/2014
2	rho-Associated KinasesIBA 06/2017 - 01/2014
2	Calcitriol (Calcijex)FDA LinkGeneric 06/2017 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 12/2010
2	Virulence Factors (Pathogenicity Factors)IBA 01/2017 - 10/2016
2	Enterotoxins (Enterotoxin)IBA 01/2017 - 10/2016
2	Coloring Agents (Dyes)IBA 12/2016 - 07/2014
2	InterleukinsIBA 12/2016 - 03/2016
2	CalciumIBA 03/2016 - 04/2008
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2016 - 01/2014
2	Connexin 43 (Connexin43)IBA 10/2015 - 01/2013
2	Sirtuin 1IBA 06/2015 - 01/2015
2	p38 Mitogen-Activated Protein KinasesIBA 01/2015 - 04/2008
2	Small Interfering RNA (siRNA)IBA 10/2014 - 07/2014
1	tussilagoneIBA 05/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	oil red OIBA 01/2022
1	Reactive Nitrogen SpeciesIBA 10/2021
1	gamma-Linolenic AcidIBA 10/2021
1	Acetylcysteine (Siran)FDA LinkGeneric 10/2021
1	Eicosapentaenoic AcidIBA 10/2021
1	Docosahexaenoic AcidsIBA 10/2021
1	saxagliptin FDA Link 07/2021
1	GhrelinIBA 06/2021
1	Malondialdehyde (Propanedial)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Interleukin-13IBA 03/2019
1	CollagenIBA 01/2019
1	indium-bleomycinIBA 01/2019
1	NivolumabIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Antihypertensive Agents (Antihypertensives)IBA 01/2019
1	BerberineIBA 01/2019
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019
1	Cortisone FDA Link 01/2019
1	ElementsIBA 01/2019
1	InterferonsIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	SmokeIBA 01/2019

Therapy/Procedure

12	Therapeutics 05/2022 - 08/2010
6	Drug Therapy (Chemotherapy) 01/2019 - 01/2011
3	Lasers (Laser) 01/2017 - 04/2008
2	Photochemotherapy (Photodynamic Therapy) 03/2022 - 01/2020
2	Immunomodulation 01/2021 - 04/2015
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 08/2015 - 01/2015
1	Bronchoscopes 02/2020
1	Noninvasive Ventilation 09/2019
1	Transplantation 03/2019